Skip to content

D&A at other companies

Nasdaq, Inc. logo
Nasdaq, Inc.NDAQ
$165M+5.8%
Alkermes logo
AlkermesALKS
$11.68M
Pfizer logo
PfizerPFE
$1.61B+33.2%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$55.9M+15.5%
Amgen logo
AmgenAMGN

Segments

By segment

See full
Fintech$888K

Other financials

Income statement

See full
Revenue$4.7M-2.8%
Gross profit$3.6M+85.6%
Operating income-$2.7M-41.0%
Net income-$271.5M-11,250%
EPS (diluted)-$2.14-1,327%

Balance sheet

See full
Cash & equivalents$10.5M-2.7%
Total debt$107.0K-99.4%
Total equity$889.7M+3,976%
Total assets$959.7M+1,130%

Cash flow

See full
Operating cash flow-$12.3M-764%
CapEx$2.8K
Free cash flow-$1.8M

Valuation

See full
Market cap$5.56B+43,568%
Enterprise value$5.55B+26,232%
P/S231.5×+231×

Profitability

See full
Gross margin46.5%+1.2pp
Operating margin-99.7%-717pp
Net margin-2,552.7%-2,601pp
FCF margin-29.7%

Returns & leverage

See full
Return on equity-134.6%-791pp
Debt / equity-0.5×
Current ratio0.8×0.0×

Where this comes from

Reported directly by Janus Living in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Janus Living ’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janus Living 's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Janus Living 's D&A?
Janus Living (JAN) reported D&A of $889K in Q1 2026.
How has Janus Living 's D&A changed year-over-year?
Janus Living 's D&A decreased by 26.5% year-over-year, from $1.21M to $889K.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.